No, you should never reuse a needle for medical injections due to severe risks like infections (Hepatitis C, HIV) and tissue damage from blunted tips
At 2.5 mg/mL, the math is remarkably clean
Summary: GLP-1 biosimilar characterization is essential for ensuring the safety, efficacy, and regulatory compliance of peptide therapeutics such as semaglutide and exenatide
The first day of GLP-1 treatment typically begins with a subcutaneous injection, usually administered in the abdomen, thigh, or upper arm
GLP-1 drugs in Europe While the GLP-1 weight-loss trend began in the US, it has quickly spread to Europe
doi:10.1177/1535370215576313 113